All podcasts
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
Anchor lead: Psilocybin’s list of conditions where it may help is expanding, Elizabeth Tracey reports The FDA is reviewing whether the hallucinogenic drug psilocybin should be reclassified to acknowledge areas where it is clinically useful, at the urging of Matthew …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Anchor lead: Should the FDA approve psilocybin as a medicine? Elizabeth Tracey reports Psilocybin is a drug that the FDA currently categorizes as having no clinical value, but an initiative underway at Johns Hopkins and several other research facilities is …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: Why are too many transfusions harmful? Elizabeth Tracey reports More and more evidence is mounting that restricting blood transfusions results in fewer problems for patients and is also less expensive, with the latest study in the New England …
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
Anchor lead: Does it make sense that an EPA product would help in cardiovascular disease? Elizabeth Tracey reports Vascepa is the name of a concentrated omega-3 fatty acid product that the manufacturer has released results about ahead of any scientific …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: An industry conducted trial is raising hopes about a fish oil product, Elizabeth Tracey reports Results from an industry-sponsored clinical trial of a concentrated fish oil product seems to show impressive reductions in cardiovascular events. The manufacturer of …
